Regulatory Compliance GLP-1 medications are subject to strict global standards, including: FDA (USA): Vaccines should be kept in validated storage with continuous monitoring between +2 C and +8 C EMA (Europe): Good Distribution Practice (GDP) requiring calibrated, validated equipment
Affected individuals carry the virus in their bodies for the rest of their lives
How much does peptide therapy cost compared to GLP-1 medications
Both sermorelin and CJC-1295/Ipamorelin are prescription medications that must be prescribed by a licensed physician and obtained from a licensed compounding pharmacy
Here's the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
doi: 10.1152/ajprenal.00125.2016 107 LevineBYuanJ